Date of preparation: November 2021.
1. Pardo G, Jones DE. The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017;264(12):2351-2374.
2. Giovannoni G, Smets I, Reyes S. MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS. Pract Neurol. 2021:77-81.